Biological E receives DCGI approval for administration of Corbevax in children aged 12 to 18 years https://ift.tt/CuxWqsp

Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) Protein subunit vaccine against COVID-19. The vaccine had already received approval for restricted use in emergency situations among adults.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/sQgux5F
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.